scholarly journals Randomized, phase II study of ficlatuzumab with or without cetuximab in patients (pts) with cetuximab-resistant, recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

2018 ◽  
Vol 29 ◽  
pp. viii399
Author(s):  
J.E. Bauman
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Neck Squamous Cell Carcinoma ◽  
Randomized Phase Ii

scholarly journals A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

2021 ◽  
Author(s):  
Ji Hyun Lee ◽  
Seong Gu Heo ◽  
Beung‐Chul Ahn ◽  
Min Hee Hong ◽  
Byoung Chul Cho ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Neck Squamous Cell Carcinoma

scholarly journals A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

2014 ◽  
Vol 25 (9) ◽  
pp. 1813-1820 ◽  
Author(s):  
T.Y. Seiwert ◽  
J. Fayette ◽  
D. Cupissol ◽  
J.M. del Campo ◽  
P.M. Clement ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Randomized Phase Ii ◽  
Recurrent Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document